Aliviado DSD Program for Dementia Caregivers
Trial Summary
Do I have to stop taking my current medications to join the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Aliviado DSD Program for Dementia Caregivers is an effective treatment?
The available research shows that similar programs to the Aliviado DSD Program, like the University of California, Los Angeles Alzheimer's and Dementia Care program, have led to improvements in caregiver depression, strain, and distress related to behavioral symptoms. Although not all participants showed improvement, most caregivers found the program very beneficial due to the support and access to dementia care experts. This suggests that the Aliviado DSD Program could also be effective in providing valuable support and improving the well-being of caregivers.12345
What safety data exists for the Aliviado DSD Program for Dementia Caregivers?
Is the Aliviado DSD Caregiving Mastery Program a promising treatment for dementia caregivers?
What is the purpose of this trial?
Delirium superimposed on dementia (DSD) is an acute and serious condition that is common in persons living with dementia (PLWD). Involvement of family caregivers may aid prevention, early detection, and management of DSD. The purpose of the proposed study is two-fold. First, the investigators will develop a family-centered, mHealth-enhanced DSD caregiving mastery program ("Aliviado DSD Caregiving Mastery Program") through a 5-week co-design workshop with 8 family caregivers (Aim 1). The investigators will adapt/refine the existing clinician-centered DSD contents and an mHealth app from the evidence-based "Aliviado Dementia Care" program for use by family caregivers to support their day-to-day implementation of DSD detection, prevention, and management tasks in the community. Second, the investigators will pilot test the full Aliviado DSD Caregiving Mastery Program with 30 family caregivers of PLWD at high risk for delirium, assessing feasibility, acceptability, app usability, and preliminary program impact (Aim 2).
Research Team
Shih-Yin Lin
Principal Investigator
NYU Rory Meyers College of Nursing
Eligibility Criteria
This trial is for English-speaking adults who provide at least 8 hours of unpaid care weekly or live with someone with dementia at high risk for delirium. They must be unfamiliar with DSD, able to consent, and have internet access via smartphone. Blind or deaf individuals cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Co-design Workshop
Development of the Aliviado DSD Caregiving Mastery Program through a 5-week co-design workshop with family caregivers
Caregiver Education/Training
Caregiver education and training period to learn about DSD prevention, detection, and management
Implementation
Implementation of the Aliviado DSD Caregiving Mastery Program by family caregivers
Follow-up
Participants are monitored for program impact, feasibility, and acceptability
Treatment Details
Interventions
- Aliviado DSD Caregiving Mastery Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute on Aging (NIA)
Collaborator